Our lab is focused on genetic diseases that affect the brain. We study the mechanisms by which mutant gene products contribute to disease, and why certain brain regions are more susceptible. The team employs advanced molecular methods, sequencing and imaging modalities in animal models. The lab is also engaged in the development of next generation therapeutics for inherited disorders, including the engineering of novel gene therapy vector capsids and cargo to approach tissue and cell type specific treatments.
Recent News
What better way to celebrate this beautiful Philadelphia spring weather than with a new lab photo?
Photo credit to our very own Dr. Luis Tecedor!
Congratulations to Dr. Defne Amado for receiving the Emerging Scholar Award for the 2023 American Neurological Association Annual Meeting! This is a great honor and were proud to see Dr. Amado’s hard work being recognized. If you would like to find out more about her award visit the ANA’s webpage: https://myana.org/about-awards/emerging-scholars-award
What we are tweeting!
-
RT @Prosser_Lab: Lovely articles from @TomAvril1 on our family and how we’re trying to fight #RareDisease @PennMedicine and… https://t.co/0sIQ15m31U
-
RT @Prosser_Lab: What a privilege to have the team and opportunity to try and help my daughter and those like her live healthier, fu… https://t.co/sbF0qVA7xJ
-
Couldn’t have said it any better on our end. An absolute honor to be part of the team that was granted this generou… https://t.co/3JRsXKVvqB
-
A massive congratulations to our graduate student Bryan Simpson for successfully defending his thesis!! 🥳🎊 https://t.co/1ynRf2wYCM
-
Always an honor to speak with @USATODAY on the monumental impact CRISPR has had on the future of science! https://t.co/Lknqa0YUAd